ARNELA ZUKANOVIC: Open Payments
NPI 1912464595 · RESTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,271 in 50 payments from 18 companies in 2025. Trend: 2023 $1,663 · 2024 $1,289 · 2025 $1,271
Food & beverage: $1,186Education: $85
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $187 |
| Incyte Corporation | 8 | $137 |
| REVANCE THERAPEUTICS, INC. | 1 | $125 |
| Janssen Biotech, Inc. | 2 | $112 |
| ABBVIE INC. | 6 | $101 |
| Organon LLC | 3 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $68 |
| GENZYME CORPORATION | 2 | $66 |
| PFIZER INC. | 3 | $64 |
| LEO Pharma Inc. | 2 | $56 |
Products named: OPZELURA, DUPIXENT, DAXXIFY, TREMFYA, Rhapsido, CIBINQO, SKYRIZI, COSENTYX.
Industry payments across VA — which companies pay providers there.
